From Laboratory to Clinic: Medicine after COVID

From Laboratory to Clinic is an annual translational research conference established in 1984. It is organised by an international committee led by past and present Directors of the Kennedy Institute, Profs Sir Marc Feldmann, Sir Ravinder Maini and Fiona Powrie. The meeting brings together basic scientists, clinicians, and industry researchers to explore how the latest discoveries in immunology and molecular medicine can be applied to improve clinical medicine.

TOPICS

• Tolerance and autoimmunity
• Microbiome
• Mitochondria and disease
• New approaches to therapeutics
• Tissue Biology
• Immunology

CONFIRMED SPEAKERS

• Larry Steinman (Stanford University, USA) 
• Jackie Perrigoue (Janssen R&D, PA, USA) 
• Aimee Payne (University of Pennsylvania, USA)
• Mala Maini (University College London, UK)
• Carola Vinuesa (Francis Crick Institute, UK)
• Fiona Powrie (University of Oxford, UK)
• Eran Elinav (Weizmann Institute of Science, Israel)
• Trevor Lawley (Sanger Institute, Cambridge UK)
• Claudia Mauri (University College London, UK)
• Kathy McCoy (University of Calgary, Canada)
• Michael Fischbach (Stanford University, USA)
• Doug Wallace (University of Pennsylvania, USA)
• Joo-Hyeon Lee (University of Cambridge, UK)
• Nebojsa Janjic (Somalogic, USA)
• Bruce Sullenger (Duke University, USA)
• Allan Jacobson (University of Massachusetts, USA)
• Aviv Regev (V) (Genentech, USA)
• Chris Buckley (University of Oxford, UK)
• Sarah Teichmann (Wellcome Sanger Institute, UK)
• Claudia Monaco (University of Oxford, UK)
• Mark Davis (Stanford University, UK)
• Galit Alter (V) (MIT/Harvard University, USA)
• Ido Amit (Weizmann Institute of Science, Israel)